107 related articles for article (PubMed ID: 3500298)
1. Corticotropin-releasing factor inhibits thermal injury.
Kiang JG; Wei ET
J Pharmacol Exp Ther; 1987 Nov; 243(2):517-20. PubMed ID: 3500298
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor inhibits neurogenic plasma extravasation in the rat paw.
Wei ET; Kiang JG; Buchan P; Smith TW
J Pharmacol Exp Ther; 1986 Sep; 238(3):783-7. PubMed ID: 2875171
[TBL] [Abstract][Full Text] [Related]
3. Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin.
Wei ET; Serda S; Tian JQ
J Pharmacol Exp Ther; 1988 Dec; 247(3):1082-5. PubMed ID: 3264573
[TBL] [Abstract][Full Text] [Related]
4. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
Turnbull AV; Vale W; Rivier C
Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
[TBL] [Abstract][Full Text] [Related]
5. Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin-releasing factor (CRF) antagonist.
Wei ET; Wong JC; Kiang JG
Regul Pept; 1990 Mar; 27(3):317-23. PubMed ID: 1970186
[TBL] [Abstract][Full Text] [Related]
6. Acute inflammatory response of the rat pawskin to acid injury is attenuated by corticotropin-releasing factor.
Tian JQ; Wei ET
Drug Chem Toxicol; 1989 Mar; 12(1):61-6. PubMed ID: 2785449
[TBL] [Abstract][Full Text] [Related]
7. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid.
McLoon LK; Wirtschafter J
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):834-41. PubMed ID: 9112978
[TBL] [Abstract][Full Text] [Related]
8. Xenopsin, neurotensin, neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury.
Gao GC; Wei ET
J Pharmacol Exp Ther; 1993 May; 265(2):619-25. PubMed ID: 8496813
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury.
Wei ET; Gao GC
Regul Pept; 1991 Apr; 33(2):93-104. PubMed ID: 1882088
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury.
Serda SM; Wei ET
Cryobiology; 1991 Apr; 28(2):185-90. PubMed ID: 2070621
[TBL] [Abstract][Full Text] [Related]
11. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
Martínez V; Rivier J; Taché Y
J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
[TBL] [Abstract][Full Text] [Related]
12. Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury.
Saria A
Br J Pharmacol; 1984 May; 82(1):217-22. PubMed ID: 6203590
[TBL] [Abstract][Full Text] [Related]
13. Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin.
Wei ET; Kiang JG
Eur J Pharmacol; 1989 Sep; 168(1):81-6. PubMed ID: 2583234
[TBL] [Abstract][Full Text] [Related]
14. Effect of peroxynitrite on plasma extravasation, microvascular blood flow and nociception in the rat.
Ridger VC; Greenacre SA; Handy RL; Halliwell B; Moore PK; Whiteman M; Brain SD
Br J Pharmacol; 1997 Nov; 122(6):1083-8. PubMed ID: 9401773
[TBL] [Abstract][Full Text] [Related]
15. Topical application of cerium nitrate prevents burn edema after burn plasma transfer.
Kremer T; Hernekamp F; Riedel K; Peter Ch; Gebhardt MM; Germann G; Heitmann Ch; Walther A
Microvasc Res; 2009 Dec; 78(3):425-31. PubMed ID: 19660480
[TBL] [Abstract][Full Text] [Related]
16. Relationship between increased vascular permeability and extravascular albumin clearance in rabbit inflammatory responses induced with Escherichia coli.
Hamilton SM; Johnston MG; Fong A; Pepevnak C; Semple JL; Movat HZ
Lab Invest; 1986 Nov; 55(5):580-7. PubMed ID: 3534449
[TBL] [Abstract][Full Text] [Related]
17. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
[TBL] [Abstract][Full Text] [Related]
18. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
Piedimonte G; Bertrand C; Geppetti P; Snider RM; Desai MC; Nadel JA
J Pharmacol Exp Ther; 1993 Jul; 266(1):270-3. PubMed ID: 7687291
[TBL] [Abstract][Full Text] [Related]
19. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
20. Adrenoceptor subtypes in the control of burn-induced plasma extravasation.
Cassuto J; Tarnow P; Yregård L; Lindblom L; Räntfors J
Burns; 2005 Mar; 31(2):123-9. PubMed ID: 15683681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
